WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Revenue

WITHUS PHARMACEUTICAL Co.,LTD. had revenue of 27.64B KRW in the quarter ending September 30, 2024, with 37.01% growth. This brings the company's revenue in the last twelve months to 105.74B, up 53.30% year-over-year. In the year 2023, WITHUS PHARMACEUTICAL Co.,LTD. had annual revenue of 80.12B with 23.87% growth.

• Revenue (ttm): 105.74B
• Revenue Growth: +53.30%
• P/S Ratio: 0.81
• Revenue / Employee: 873.87M
• Employees: 121
• Market Cap: 85.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	80.12B	15.44B	23.87%
Dec 31, 2022	64.68B	7.26B	12.65%
Dec 31, 2021	57.42B	4.01B	7.51%
Dec 31, 2020	53.41B	1.01B	1.93%
Jun 30, 2020	52.39B	661.12M	1.28%